Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ludlow China Fund, Inc. was a New York-based investment company primarily known for owning and operating the Ludlow China SmallCap Index. Active in the mid-2000s, the firm focused on tracking and providing exposure to U.S.-traded over-the-counter (OTC) and small-cap Chinese stocks. While it operated during a period of significant growth in the Chinese emerging market, it was an investment vehicle rather than a biotechnology or life sciences developer. The fund provided institutional and individual investors with a gauge for tracking the performance of diversified baskets of Chinese equities across various sectors, including technology and manufacturing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ludlow China Fund.